trastuzumab
Not Tagged
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)']
#asco23 nine-weeks vs one-year trastuzumab for early-stage her2+ bc: 10-year update of the short-her trial the standard duration of treatment is 1 year however, shorter duration of tastuzumab appears to be safe in low-risk pts such as n0 presented by dr. pier franco 
Medical Oncologist.                                            
        
On the trail of #SCIENCE to turn cancer into a manageable chronic disease. #bcsm #crcsm